Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes

NCT00997243 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Drug no longer being supplied by sponsor

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: lintuzumab
DRUG: 5-azacytidine

Sponsor

Alison Walker

Collaborators

[object Object]